Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Annals of Surgery|February 19, 2021
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter StudyXufeng Guo, Zhexin Wang, Hong Yang, et al.
Journal of Thoracic Disease|December 13, 2023
Collaborative multidisciplinary management and expertise of cT2-3 locally advanced operable esophageal squamous cell carcinoma: a report of two casesXuefeng Leng, Daisuke Kurita, Yi Zhu, et al.
Annals of Surgery|December 20, 2019
Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter StudyXuefeng Leng, Wenwu He, Hong Yang, et al.
JAMA Surgery|June 23, 2021
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical TrialHong Yang, Hui Liu, Yuping Chen, et al.
International Journal of Surgery (London, England)|September 24, 2025
Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world studyChunji Chen, Ziqiang Tian, Jiangbo Lin, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 10, 2025
Lymph node dissection in neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter real-world studyChunji Chen, Huilai Lv, Jinbo Zhao, et al.
JAMA Surgery|March 19, 2025
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell CarcinomaXufeng Guo, Chunji Chen, Jinbo Zhao, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 22, 2022
Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010Dong Chen, Min Kong, Jiajing Sun, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 29, 2026
Survival Differences Among Non-pCR Patients with Distinct Pathological Outcomes After Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaHainan Chen, Chunji Chen, Huilai Lv, et al.
Annals of Translational Medicine|November 18, 2021
Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010)Jianfei Shen, Min Kong, Hong Yang, et al.
Pageof 10